When Is It Time to Stop Taking GLP-1 Meds?

---

“Taking a break from GLP-1 medications can cause natural digestive signals to return within days.”

Typically, it is time to stop (or pause) GLP-1 medications when a patient: experiences intolerable gastrointestinal side effects, reaches a target weight or treatment milestone, needs to clear the drug from their system one to two weeks prior to surgery requiring anesthesia, or faces financial barriers like a loss of insurance coverage. However, should that happen, experts suggest stopping the medication suddenly may require a managed transition for chronic conditions.

There are times when people may still want to lose more weight but have real reasons to discontinue use of a glucagon-like peptide-1 receptor agonists like semaglutide or tirzepatide. The onset of fatigue, which generally tops the list of common reasons why they decided it might be time to stop, is followed closely by persistent side effects, monthly out-of-pocket costs, and difficulty in accessing the GLP-1 medications they specifically need.

While clinical guidelines view the use of GLP-1s for treatment of obesity or type 2 diabetes as chronic conditions that may require lifelong treatment, real-world data suggests that about 50% to 60% of those using these revolutionary incretin mimetics stop GLP-1 medications within one year. Moreover, statistics show that only about 14% to 20% of prescriptive GLP-1 weight loss patients remain on the medication at the three-year mark. Some experts recommend indefinite use because a driving appetite can return once the person decides that it is time to stop.

What happens if you take a break from GLP-1 meds?

Within a few days of taking a break from a GLP-1 medication, your natural appetite and digestive signals will return. Naturally, this leads to increased feelings of hunger, the return of “food noise,” rising blood sugar levels, and gradual weight regain. Unfortunately, the weight regained is often adipose (fat) tissue, so it is not time to stop resistance band training when you stop taking a GLP-1. Nonetheless, taking a break from a receptor agonist can reduce common gastrointestinal side effects like nausea, bloating, or acid reflux. If you stop for more than a couple of weeks, restarting a GLP-1 at your old dosage can cause severe stomach upset. That’s why your doctor will likely restart your medical weight loss program at the lowest initial dose to build dosing levels back up slowly.

Can you cycle on and off GLP-1 medications?

Although you can physically stop taking a GLP-1 medication and start taking it again, medical experts do not recommend “cycling off” and “cycling on” as a weight management strategy. Stopping these drugs leads to return of hunger followed by significant weight regain, and consecutive cycles of doing this may make the medication less effective at regulating appetite hormones and weight yo-yoing can negatively alter your body composition by increasing fat deposits relative to the loss of muscle mass. Additionally, studies show that people who cycle off-and-on may struggle to ever return to their lowest previous weight after restarting the drug. Even when having surgery, doctors usually recommend only a temporary stop to lower aspiration risks, or anytime the drug’s side effects become completely unmanageable.

Does anyone keep weight off after stopping a GLP-1s?

Yes, some people do keep weight off after stopping GLP-1 medications like semaglutide or tirzepatide, but clinical data shows that the majority of patients regain a significant portion of the lost weight and often rather quickly. Ongoing studies indicate that without the medication's continuous appetite-regulating effects, patients typically regain about two-thirds to three-quarters of the lost weight within one to two years. However, a notable percentage (about 45% to 55%) of patients manage to avoid total regain or continue losing weight as weight trajectories often plateau. Around a quarter of patients can expect to experience a total return to their pre-treatment weight within two years of the time to stop.

What Factors Impact Weight Maintenance Using a GLP-1?

According to data studies monitored by Cleveland Clinic, individuals taking prescription glucagon-like peptide-1 receptor agonists for type 2 diabetes often show more stable post-cessation weight trends compared to those treating chronic weight management (obesity). Instead of a lack of willpower, obesity functions as a chronically-relapsing metabolic condition. Fact is, obese individuals may not have the biological appetite regulation when taking an incretin mimetic and their body’s natural hormone response may drive weight regain.

However, one-on-one support like that provided by MRC Evansville may provide the mechanisms needed for obese patients to maintain a personalized protein-forward menu plan, routine resistance exercises to help preserve muscle mass, as well as the ongoing lifestyle coaching needed after stopping GLP-1 medications to avoid a rapid rebound. Since biological hunger cues do return once the drug leaves the patient’s system, long-term weight maintenance will always be challenging without a clear-cut transition plan.

When your weight stalls and stays exactly the same for three to four weeks while taking a prescriptive GLP-1 weight loss medication, you may have reached a weight loss plateau. Short stalls of a couple of weeks are normal shifts and do not count as a true plateau. In fact, you may lose visceral belly fat and build muscle mass at the same time, which keeps the weight displayed on your bathroom scale the same, but your overall results were positive. Moreover, water retention after hard workouts or higher sodium (salt) intake can actually mask fat loss with increased water weight.

______________________

Generally speaking, you should only stop taking prescription GLP-1 medications under the direct guidance of a doctor, as obesity and type 2 diabetes are chronic conditions that usually require long-term management for sustainable results. Valid reasons to stop or pause treatments with glucagon-like peptide-1 agonists include reaching one’s target weight, experiencing severe side effects, facing high costs, loss of insurance coverage, or preparing for scheduled surgeries to lower aspiration risks when anesthesia is required. Anesthesiologists often pause GLP-1 use for one to two weeks before procedures to prevent delayed gastric emptying. At Metabolic Research Center Evansville, our goal is to provide the GLP-1 support needed to create a customized program that preserves crucial muscle mass, limits the common side effects of using a GLP-1 receptor agonist, and produces the changes your body needs for sustainable weight control.